We are live on
!
Find out more
ZEAL
Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL
Delisted
ZEAL was delisted on the 29th of September, 2022.
16 hedge funds and large institutions have $39.5M invested in Zealand Pharma A/S American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
18% less capital invested
Capital invested by funds: $47.9M → $39.5M (-$8.4M)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
6
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$393K |
| 2 |
JCM
Jacobi Capital Management
Pittston,
Pennsylvania
|
+$29.2K |
| 3 |
US Bancorp
Minneapolis,
Minnesota
|
+$10.9K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$1.97K |
| 5 |
BlackRock
New York
|
+$905 |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.15M |
| 2 |
Jane Street
New York
|
-$262K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$36.6K |
| 4 |
Morgan Stanley
New York
|
-$18.4K |
| 5 |
SWM
Spire Wealth Management
Mclean,
Virginia
|
-$10K |
